Search

everythinglearnresearchcommunity

for

Search:↓

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Oral isotretinoin effectively treats yellow facial papules in frontal fibrosing alopecia patients.

Black women with CCCA are more likely to have uterine fibroids.

Calcitriol and metformin together are more effective for treating PCOS and lowering MCP-1 than metformin alone.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

New compounds show promise as nonsteroidal treatments for hair loss.

Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Prescription tablets treat hirsutism, while over-the-counter foams treat hypertrichosis.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Tofacitinib might be used to treat hair loss.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Low-dose isotretinoin and erythromycin effectively treated hair loss in two young sisters.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

There are various treatment options for frontal fibrosing alopecia.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

LDL apheresis lowers inflammation and cardiovascular risk by reducing CRP levels long-term.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Clindamycin and rifampicin are the most effective treatments for folliculitis decalvans, but more research is needed.

Tofacitinib may effectively treat folliculitis decalvans.